The use of IFN-alpha in subjects with liver transplant for hepatitis C.
A
A
Gattoni
E
E
Plaitano
B
B
Vangieri
A
A
Parlato
A
A
Giordano
D000998:Antiviral Agents / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006526:Hepatitis C / Q000276:immunology / Q000601:surgery*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation; D055502:Secondary Prevention; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha